false
0000065770
0000065770
2024-11-07
2024-11-07
iso4217:USD
xbrli:shares
iso4217:USD
xbrli:shares
UNITED
STATES
SECURITIES
AND EXCHANGE COMMISSION
Washington,
D.C. 20549
FORM
8-K
CURRENT
REPORT
PURSUANT
TO SECTION 13 OR 15(d) OF
THE
SECURITIES EXCHANGE ACT OF 1934
DATE
OF REPORT (DATE OF EARLIEST EVENT REPORTED) November 7, 2024
MicroVision,
Inc.
(Exact
name of registrant as specified in its charter)
Delaware |
|
001-34170 |
|
91-1600822 |
(State
or other jurisdiction
of
incorporation) |
|
(Commission
File
Number) |
|
(I.R.S.
Employer
Identification
No.) |
18390
NE 68th Street
Redmond,
Washington 98052
(Address
of principal executive offices) (Zip code)
(425)
936-6847
(Registrant’s
telephone number, including area code)
Not
Applicable
(Former
name or former address if changed since last report)
Check
the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under
any of the following provisions:
|
☐ |
Written
communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) |
|
|
|
|
☐ |
Soliciting
material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) |
|
|
|
|
☐ |
Pre-commencement
communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) |
|
|
|
|
☐ |
Pre-commencement
communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) |
Securities
registered pursuant to Section 12(b) of the Act:
Title
of each class |
|
Trading
symbol(s) |
|
Name
of each exchange on which registered |
Common
stock, par value $0.001 per share |
|
MVIS |
|
The
NASDAQ Stock Market |
Indicate
by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405
of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
Emerging
growth company ☐
If
an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying
with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
Item
2.02. Results of Operations and Financial Condition.
The
information in this Current Report is being furnished and shall not be deemed “filed” for the purposes of Section 18 of the
Securities Exchange Act of 1934, as amended, or otherwise subject to the liabilities of that Section. The information in this Current
Report shall not be incorporated by reference into any registration statement or other document pursuant to the Securities Act of 1933,
as amended.
On
November 7, 2024, MicroVision, Inc. issued a press release announcing its third quarter 2024 results. A copy of the press release is
attached as Exhibit 99.1 and is incorporated herein by reference.
Item
9.01. Financial Statements and Exhibits.
(c)
Exhibits.
Pursuant
to the rules and regulations of the SEC, the attached exhibit is deemed to have been furnished to, but not filed with, the SEC.
SIGNATURE
Pursuant
to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by
the undersigned hereunto duly authorized.
|
MICROVISION,
INC. |
|
|
|
|
By: |
/s/
Drew G. Markham |
|
|
Drew
G. Markham |
|
|
Senior
Vice President, General Counsel and Secretary |
Dated:
November 7, 2024
Exhibit
99.1
MicroVision
Announces Third Quarter 2024 Results
REDMOND,
WA / ACCESSWIRE / November 7, 2024 / MicroVision, Inc. (NASDAQ:MVIS), a leader in MEMS-based solid-state automotive lidar and ADAS solutions,
today announced its third quarter 2024 results.
Key
Business Highlights for Q3 2024
| ● | Actively
engaged with top-tier global automotive OEMs, with seven high-volume RFQs for passenger vehicles
and custom development opportunities. |
| ● | Actively
engaged with multiple leading industrial companies for the opportunity to provide an integrated
lidar hardware and software solution in the heavy equipment vertical. |
| ● | Sequential
improvement in cash burn in the third quarter of 2024 positioned the Company well to leverage
near-term hardware and software sales to industrial customers. |
“We
believe the recently executed $75 million capital commitment positions us well to secure additional revenue opportunities for 2025 and
beyond with our integrated MOVIA L and software solution with multiple industrial customers in the heavy equipment segment,” said
Sumit Sharma, MicroVision’s Chief Executive Officer. “In addition, MAVIN and MOVIA S, combined with our integrated perception
software, continue to offer compelling solutions to automotive OEMs at attractive price points. Given automotive OEMs’ latest start-of-production
timelines, the opportunity to ramp revenues in 2025 with our industrial customers puts MicroVision in a strong position in the marketplace.”
“With
a watchful eye on our operating expenses, we are pleased with the steady improvement in our cash burn, showing sequential reductions
for the first three quarters of 2024,” continued Sharma. “We expect to continue scaling resources, both internally and with
third party vendors and suppliers, as we remain engaged with automotive OEMs and responsive to their evolving timelines.”
Key
Financial Highlights for Q3 2024
| ● | Revenue
for the third quarter of 2024 was $0.2 million, compared to $1.0 million for the third quarter
of 2023, with the year-over-year fluctuation driven by a delayed order, as well as the 2023
sale of MOSAIK software to a leading Asian automotive OEM. |
| ● | Net
loss for the third quarter of 2024 was $15.5 million, or $0.07 per share, which includes
$2.4 million of non-cash, share-based compensation expense, compared to a net loss of $23.5
million, or $0.12 per share, which includes $4.7 million of non-cash, share-based compensation
expense, for the third quarter of 2023. |
| ● | Adjusted
EBITDA for the third quarter of 2024 was an $11.7 million loss, compared to a $16.9 million
loss for the third quarter of 2023. |
| ● | Cash
used in operations in the third quarter of 2024 was $14.1 million, compared to cash
used in operations in the third quarter of 2023 of $20.4 million. |
| ● | The
Company ended the third quarter of 2024 with $43.2 million in cash and cash equivalents,
including investment securities, compared to $73.8 million at December 31, 2023. |
Subsequent
to the third quarter, the Company strengthened its financial position by closing on a two-year $75.0 million senior secured convertible
note facility in October 2024. After giving effect to the net proceeds from the first $45.0 million tranche of the financing transaction,
the Company expects to have approximately $81 million in cash and cash equivalents and access to $153 million of additional capital,
including $123 million under its existing ATM, or at-the-market, facility and $30 million from the remaining commitment pursuant to the
convertible note facility.
Conference
Call and Webcast: Q3 2024 Results
MicroVision
will host a conference call and webcast, consisting of prepared remarks by management, a slide presentation, and a question-and-answer
session at 1:30 PM PT/4:30 PM ET on Thursday, November 7, 2024 to discuss the financial results and provide a business update. Analysts
and investors may pose questions to management during the live webcast on November 7, 2024.
The
live webcast and slide presentation can be accessed on the Company’s Investor Relations website under the Events tab at https://ir.microvision.com/events.
The webcast will be archived on the website for future viewing.
About
MicroVision
With
offices in the U.S. and Germany, MicroVision is a pioneering company in MEMS-based laser beam scanning technology that integrates MEMS,
lasers, optics, hardware, algorithms and machine learning software into its proprietary technology to address existing and emerging markets.
The Company’s integrated approach uses its proprietary technology to provide automotive lidar sensors and solutions for advanced
driver-assistance systems (ADAS) and for non-automotive applications including industrial, smart infrastructure and robotics. The Company
has been leveraging its experience building augmented reality micro-display engines, interactive display modules, and consumer lidar
modules.
For
more information, visit the Company’s website at www.microvision.com, on Facebook at www.facebook.com/microvisioninc,
and LinkedIn at https://www.linkedin.com/company/microvision/.
MicroVision,
MAVIN, MOSAIK, and MOVIA are trademarks of MicroVision, Inc. in the United States and other countries. All other trademarks are the properties
of their respective owners.
Non-GAAP
information
To
supplement MicroVision’s condensed financial statements presented in accordance with GAAP, the Company presents investors with
the non-GAAP financial measures “adjusted EBITDA” and “adjusted Gross Profit.” Adjusted EBITDA consists of GAAP
net income (loss) excluding the impact of the following: interest income and interest expense; income tax expense; depreciation and amortization;
bargain purchase gain; share-based compensation; impairment charges; and restructuring costs. Adjusted Gross Profit is calculated as
GAAP gross profit before share-based compensation expense and the amortization of acquired intangibles included in cost of revenue.
MicroVision
believes that the presentation of adjusted EBITDA and adjusted Gross Profit provides important supplemental information to management
and investors regarding financial and business trends, provides consistency and comparability with MicroVision’s past financial
reports, and facilitates comparisons with other companies in the Company’s industry, many of which use similar non-GAAP financial
measures to supplement their GAAP results. Internally, management uses these non-GAAP measures when evaluating operating performance
because the exclusion of the items described above provides an additional useful measure of the Company’s operating results and
facilitates comparisons of the Company’s core operating performance against prior periods and its business objectives. Externally,
the Company believes that adjusted EBITDA and adjusted Gross Profit are useful to investors in their assessment of MicroVision’s
operating performance and the valuation of the Company.
Adjusted
EBITDA and adjusted Gross Profit are not calculated in accordance with GAAP, and should be considered supplemental to, and not as a substitute
for, or superior to, financial measures calculated in accordance with GAAP. Non-GAAP financial measures have limitations in that they
do not reflect all of the costs associated with the operations of MicroVision’s business as determined in accordance with GAAP.
The Company expects to continue to incur expenses similar to the non-GAAP adjustments described above, and exclusion of these items from
its non-GAAP financial measures should not be construed as an inference that these costs are unusual or infrequent.
The
Company compensates for limitations of the adjusted EBITDA measure by prominently disclosing GAAP net income (loss), which the Company
believes is the most directly comparable GAAP measure, and providing investors with a reconciliation from GAAP net income (loss) to adjusted
EBITDA.
Similarly
for adjusted Gross Profit, the Company compensates for limitations of the measure by prominently disclosing GAAP gross profit which is
the difference between Revenue and Cost of revenue, which the Company believes is the most directly comparable GAAP measure, and providing
investors with a reconciliation by backing out share-based compensation expense and the amortization of acquired intangibles included
in cost of revenue.
Forward-Looking
Statements
Certain
statements contained in this release, including customer engagement and the likelihood of success; opportunities for revenue and cash;
expense reduction; market position; product portfolio; product and manufacturing capabilities; capital-raising opportunities; and expected
revenue, expenses and cash usage are forward-looking statements that involve a number of risks and uncertainties that could cause actual
results to differ materially from those in the forward-looking statements. Factors that could cause actual results to differ materially
from those projected in such forward-looking statements include the risk its ability to operate with limited cash or to raise additional
capital when needed; market acceptance of its technologies and products or for products incorporating its technologies; the failure of
its commercial partners to perform as expected under its agreements; its financial and technical resources relative to those of its competitors;
its ability to keep up with rapid technological change; government regulation of its technologies; its ability to enforce its intellectual
property rights and protect its proprietary technologies; the ability to obtain customers and develop partnership opportunities; the
timing of commercial product launches and delays in product development; the ability to achieve key technical milestones in key products;
dependence on third parties to develop, manufacture, sell and market its products; potential product liability claims; its ability to
maintain its listing on The Nasdaq Stock Market, and other risk factors identified from time to time in the Company’s SEC reports,
including the Company’s Annual Report on Form 10-K, Quarterly Reports on Form 10-Q and other reports filed with the SEC. These
factors are not intended to represent a complete list of the general or specific factors that may affect the Company. It should be recognized
that other factors, including general economic factors and business strategies, may be significant, now or in the future, and the factors
set forth in this release may affect the Company to a greater extent than indicated. Except as expressly required by federal securities
laws, the Company undertakes no obligation to publicly update or revise any forward-looking statements, whether as a result of new information,
future events, changes in circumstances or any other reason.
Investor
Relations Contact
Jeff
Christensen
Darrow
Associates Investor Relations
MVIS@darrowir.com
Media
Contact
Marketing@MicroVision.com
Source:
MicroVision, Inc.
Microvision,
Inc.
Consolidated
Balance Sheet
(In
thousands)
(Unaudited)
| |
September 30, | | |
December 31, | |
| |
2024 | | |
2023 | |
| |
| | |
| |
Assets | |
| | | |
| | |
Current Assets | |
| | | |
| | |
Cash and cash equivalents | |
$ | 16,523 | | |
$ | 45,167 | |
Investment securities, available-for-sale | |
| 26,679 | | |
| 28,611 | |
Restricted cash, current | |
| 270 | | |
| 3,263 | |
Accounts receivable, net of allowances | |
| 232 | | |
| 949 | |
Inventory | |
| 4,486 | | |
| 3,874 | |
Other current assets | |
| 4,857 | | |
| 4,890 | |
Total current assets | |
| 53,047 | | |
| 86,754 | |
| |
| | | |
| | |
Property and equipment, net | |
| 7,668 | | |
| 9,032 | |
Operating lease right-of-use assets | |
| 12,090 | | |
| 13,758 | |
Restricted cash, net of current portion | |
| 1,572 | | |
| 961 | |
Intangible assets, net | |
| 12,563 | | |
| 17,235 | |
Other assets | |
| 1,322 | | |
| 1,895 | |
Total assets | |
$ | 88,262 | | |
$ | 129,635 | |
| |
| | | |
| | |
Liabilities and Shareholders’ Equity | |
| | | |
| | |
Current Liabilities | |
| | | |
| | |
Accounts payable | |
$ | 1,487 | | |
$ | 2,271 | |
Accrued liabilities | |
| 5,893 | | |
| 8,640 | |
Accrued liability for Ibeo business combination | |
| - | | |
| 6,300 | |
Contract liabilities | |
| 180 | | |
| 300 | |
Operating lease liabilities, current | |
| 2,149 | | |
| 2,323 | |
Other current liabilities | |
| 902 | | |
| 669 | |
Total current liabilities | |
| 10,611 | | |
| 20,503 | |
| |
| | | |
| | |
Operating lease liabilities, net of current portion | |
| 11,662 | | |
| 12,714 | |
Other long-term liabilities | |
| 134 | | |
| 614 | |
Total liabilities | |
| 22,407 | | |
| 33,831 | |
| |
| | | |
| | |
Commitments and contingencies | |
| | | |
| | |
Shareholders’ Equity | |
| | | |
| | |
Common stock at par value | |
| 213 | | |
| 195 | |
Additional paid-in capital | |
| 896,424 | | |
| 860,765 | |
Accumulated other comprehensive income | |
| 344 | | |
| 210 | |
Accumulated deficit | |
| (831,126 | ) | |
| (765,366 | ) |
Total shareholders’ equity | |
| 65,855 | | |
| 95,804 | |
Total liabilities and shareholders’ equity | |
$ | 88,262 | | |
$ | 129,635 | |
MicroVision,
Inc.
Consolidated
Statement of Operations
(In
thousands, except earnings per share data)
(Unaudited)
| |
Three months ended
September 30, | | |
Nine months ended
September 30, | |
| |
2024 | | |
2023 | | |
2024 | | |
2023 | |
| |
| | |
| | |
| | |
| |
Revenue | |
$ | 190 | | |
$ | 1,047 | | |
$ | 3,046 | | |
$ | 2,158 | |
| |
| | | |
| | | |
| | | |
| | |
Cost of revenue | |
| 583 | | |
| 625 | | |
| 3,414 | | |
| 1,870 | |
Gross profit (loss) | |
| (393 | ) | |
| 422 | | |
| (368 | ) | |
| 288 | |
| |
| | | |
| | | |
| | | |
| | |
Research and development expense | |
| 8,736 | | |
| 15,584 | | |
| 40,251 | | |
| 42,127 | |
Sales, marketing, general and administrative expense | |
| 6,599 | | |
| 8,743 | | |
| 23,423 | | |
| 27,172 | |
Impairment of intangible assets | |
| - | | |
| - | | |
| 3,027 | | |
| - | |
Gain on disposal of fixed assets | |
| (22 | ) | |
| (10 | ) | |
| (22 | ) | |
| (25 | ) |
Total operating expenses | |
| 15,313 | | |
| 24,317 | | |
| 66,679 | | |
| 69,274 | |
| |
| | | |
| | | |
| | | |
| | |
Loss from operations | |
| (15,706 | ) | |
| (23,895 | ) | |
| (67,047 | ) | |
| (68,986 | ) |
| |
| | | |
| | | |
| | | |
| | |
Bargain purchase gain, net of tax | |
| - | | |
| - | | |
| - | | |
| 1,706 | |
Other income, net | |
| 297 | | |
| 637 | | |
| 1,713 | | |
| 4,846 | |
| |
| | | |
| | | |
| | | |
| | |
Net loss before taxes | |
$ | (15,409 | ) | |
$ | (23,258 | ) | |
$ | (65,334 | ) | |
$ | (62,434 | ) |
| |
| | | |
| | | |
| | | |
| | |
Income tax expense | |
| (108 | ) | |
| (211 | ) | |
| (426 | ) | |
| (671 | ) |
| |
| | | |
| | | |
| | | |
| | |
Net loss | |
$ | (15,517 | ) | |
$ | (23,469 | ) | |
$ | (65,760 | ) | |
$ | (63,105 | ) |
| |
| | | |
| | | |
| | | |
| | |
Net loss per share - basic and diluted | |
$ | (0.07 | ) | |
$ | (0.12 | ) | |
$ | (0.32 | ) | |
$ | (0.35 | ) |
| |
| | | |
| | | |
| | | |
| | |
Weighted-average shares outstanding - basic and diluted | |
| 213,004 | | |
| 188,306 | | |
| 206,164 | | |
| 180,156 | |
Microvision,
Inc.
Consolidated
Statement of Cash Flows
(In
thousands)
(Unaudited)
| |
Nine months ended September 30, | |
| |
2024 | | |
2023 | |
| |
| | |
| |
Cash flows from operating activities | |
| | | |
| | |
Net loss | |
$ | (65,760 | ) | |
$ | (63,105 | ) |
Adjustments to reconcile net loss to net cash used in operations | |
| | | |
| | |
Depreciation and amortization | |
| 5,246 | | |
| 6,288 | |
Bargain purchase gain, net of tax | |
| - | | |
| (1,706 | ) |
Gain on disposal of fixed assets | |
| (22 | ) | |
| (25 | ) |
Impairment of intangible assets | |
| 3,027 | | |
| - | |
Impairment of operating lease right-of-use assets | |
| 406 | | |
| - | |
Impairment of property and equipment | |
| - | | |
| 12 | |
Inventory write-down | |
| 127 | | |
| 61 | |
Share-based compensation expense | |
| 9,522 | | |
| 11,506 | |
Net accretion of premium on short-term investments | |
| (776 | ) | |
| (986 | ) |
Change in: | |
| | | |
| | |
Accounts receivable | |
| 717 | | |
| (740 | ) |
Inventory | |
| (723 | ) | |
| (619 | ) |
Other current and non-current assets | |
| 606 | | |
| (3,214 | ) |
Accounts payable | |
| (784 | ) | |
| 896 | |
Accrued liabilities | |
| (2,747 | ) | |
| 4,321 | |
Contract liabilities and other current liabilities | |
| 109 | | |
| (1,405 | ) |
Operating lease liabilities | |
| (1,944 | ) | |
| (1,813 | ) |
Other long-term liabilities | |
| (488 | ) | |
| 17 | |
Net cash used in operating activities | |
| (53,484 | ) | |
| (50,512 | ) |
| |
| | | |
| | |
Cash flows from investing activities | |
| | | |
| | |
Sales of investment securities | |
| 28,311 | | |
| 61,700 | |
Purchases of investment securities | |
| (25,570 | ) | |
| (27,101 | ) |
Cash paid for Ibeo business combination | |
| (6,300 | ) | |
| (11,233 | ) |
Purchases of property and equipment | |
| (271 | ) | |
| (1,981 | ) |
Net cash (used in) provided by investing activities | |
| (3,830 | ) | |
| 21,385 | |
| |
| | | |
| | |
Cash flows from financing activities | |
| | | |
| | |
Principal payments under finance leases | |
| - | | |
| (19 | ) |
Proceeds from stock option exercises | |
| 62 | | |
| 175 | |
Net proceeds from issuance of common stock | |
| 26,093 | | |
| 60,607 | |
Net cash provided by financing activities | |
| 26,155 | | |
| 60,763 | |
| |
| | | |
| | |
Effect of exchange rate changes on cash and cash equivalents and restricted cash | |
| 133 | | |
| - | |
| |
| | | |
| | |
Net increase (decrease) in cash and cash equivalents | |
| (31,026 | ) | |
| 31,636 | |
Cash, cash equivalents and restricted cash at beginning of period | |
| 49,391 | | |
| 21,954 | |
| |
| | | |
| | |
Cash, cash equivalents and restricted cash at end of period | |
$ | 18,365 | | |
$ | 53,590 | |
The following table provides
a reconciliation of the cash, cash equivalents, and restricted cash balances as of September 30, 2024 and 2023:
| |
September 30, | | |
September 30, | |
| |
2024 | | |
2023 | |
Cash and cash equivalents | |
$ | 16,523 | | |
$ | 49,366 | |
Restricted cash, current | |
| 270 | | |
| 3,263 | |
Restricted cash, net of current portion | |
| 1,572 | | |
| 961 | |
Cash, cash equivalents and restricted cash | |
$ | 18,365 | | |
$ | 53,590 | |
MicroVision,
Inc.
Reconciliation
of GAAP to Non-GAAP Measures
(In
thousands)
(Unaudited)
| |
Three months ended
September 30, | | |
Nine months ended
September 30, | |
| |
2024 | | |
2023 | | |
2024 | | |
2023 | |
| |
| | |
| | |
| | |
| |
Reconciliation of Non-GAAP Gross Profit (Loss): | |
| | | |
| | | |
| | | |
| | |
Gross profit (loss) | |
$ | (393 | ) | |
$ | 422 | | |
$ | (368 | ) | |
$ | 288 | |
Share-based compensation expense | |
| - | | |
| - | | |
| - | | |
| - | |
Amortization of acquired intangibles | |
| 361 | | |
| 387 | | |
| 1,135 | | |
| 1,029 | |
Adjusted Gross Profit (Loss) | |
$ | (32 | ) | |
$ | 809 | | |
$ | 767 | | |
$ | 1,317 | |
| |
| | | |
| | | |
| | | |
| | |
Reconciliation of Non-GAAP Loss: | |
| | | |
| | | |
| | | |
| | |
GAAP Net loss | |
$ | (15,517 | ) | |
$ | (23,469 | ) | |
$ | (65,760 | ) | |
$ | (63,105 | ) |
Interest, net | |
| (462 | ) | |
| (509 | ) | |
| (1,570 | ) | |
| (1,725 | ) |
Income taxes | |
| 108 | | |
| 211 | | |
| 426 | | |
| 671 | |
Depreciation and amortization | |
| 1,676 | | |
| 2,137 | | |
| 5,246 | | |
| 6,288 | |
Bargain purchase gain, net of tax | |
| - | | |
| - | | |
| - | | |
| (1,706 | ) |
Share-based compensation expense | |
| 2,426 | | |
| 4,691 | | |
| 9,522 | | |
| 11,506 | |
Impairment of operating lease right-of-use assets | |
| 13 | | |
| - | | |
| 406 | | |
| - | |
Impairment of intangible assets | |
| - | | |
| - | | |
| 3,027 | | |
| - | |
Restructuring costs | |
| 90 | | |
| - | | |
| 5,804 | | |
| - | |
Adjusted EBITDA | |
$ | (11,666 | ) | |
$ | (16,939 | ) | |
$ | (42,899 | ) | |
$ | (48,071 | ) |
v3.24.3
X |
- DefinitionBoolean flag that is true when the XBRL content amends previously-filed or accepted submission.
+ References
+ Details
Name: |
dei_AmendmentFlag |
Namespace Prefix: |
dei_ |
Data Type: |
xbrli:booleanItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionFor the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD.
+ References
+ Details
Name: |
dei_DocumentPeriodEndDate |
Namespace Prefix: |
dei_ |
Data Type: |
xbrli:dateItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionThe type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.
+ References
+ Details
Name: |
dei_DocumentType |
Namespace Prefix: |
dei_ |
Data Type: |
dei:submissionTypeItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionAddress Line 1 such as Attn, Building Name, Street Name
+ References
+ Details
Name: |
dei_EntityAddressAddressLine1 |
Namespace Prefix: |
dei_ |
Data Type: |
xbrli:normalizedStringItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- Definition
+ References
+ Details
Name: |
dei_EntityAddressCityOrTown |
Namespace Prefix: |
dei_ |
Data Type: |
xbrli:normalizedStringItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionCode for the postal or zip code
+ References
+ Details
Name: |
dei_EntityAddressPostalZipCode |
Namespace Prefix: |
dei_ |
Data Type: |
xbrli:normalizedStringItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionName of the state or province.
+ References
+ Details
Name: |
dei_EntityAddressStateOrProvince |
Namespace Prefix: |
dei_ |
Data Type: |
dei:stateOrProvinceItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionA unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.
+ ReferencesReference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Exchange Act -Number 240 -Section 12 -Subsection b-2
+ Details
Name: |
dei_EntityCentralIndexKey |
Namespace Prefix: |
dei_ |
Data Type: |
dei:centralIndexKeyItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionIndicate if registrant meets the emerging growth company criteria.
+ ReferencesReference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Exchange Act -Number 240 -Section 12 -Subsection b-2
+ Details
Name: |
dei_EntityEmergingGrowthCompany |
Namespace Prefix: |
dei_ |
Data Type: |
xbrli:booleanItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionCommission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.
+ References
+ Details
Name: |
dei_EntityFileNumber |
Namespace Prefix: |
dei_ |
Data Type: |
dei:fileNumberItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionTwo-character EDGAR code representing the state or country of incorporation.
+ References
+ Details
Name: |
dei_EntityIncorporationStateCountryCode |
Namespace Prefix: |
dei_ |
Data Type: |
dei:edgarStateCountryItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionThe exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.
+ ReferencesReference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Exchange Act -Number 240 -Section 12 -Subsection b-2
+ Details
Name: |
dei_EntityRegistrantName |
Namespace Prefix: |
dei_ |
Data Type: |
xbrli:normalizedStringItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionThe Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.
+ ReferencesReference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Exchange Act -Number 240 -Section 12 -Subsection b-2
+ Details
Name: |
dei_EntityTaxIdentificationNumber |
Namespace Prefix: |
dei_ |
Data Type: |
dei:employerIdItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionLocal phone number for entity.
+ References
+ Details
Name: |
dei_LocalPhoneNumber |
Namespace Prefix: |
dei_ |
Data Type: |
xbrli:normalizedStringItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionBoolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.
+ ReferencesReference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Exchange Act -Number 240 -Section 13e -Subsection 4c
+ Details
Name: |
dei_PreCommencementIssuerTenderOffer |
Namespace Prefix: |
dei_ |
Data Type: |
xbrli:booleanItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionBoolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.
+ ReferencesReference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Exchange Act -Number 240 -Section 14d -Subsection 2b
+ Details
Name: |
dei_PreCommencementTenderOffer |
Namespace Prefix: |
dei_ |
Data Type: |
xbrli:booleanItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionTitle of a 12(b) registered security.
+ ReferencesReference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Exchange Act -Number 240 -Section 12 -Subsection b
+ Details
Name: |
dei_Security12bTitle |
Namespace Prefix: |
dei_ |
Data Type: |
dei:securityTitleItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionName of the Exchange on which a security is registered.
+ ReferencesReference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Exchange Act -Number 240 -Section 12 -Subsection d1-1
+ Details
Name: |
dei_SecurityExchangeName |
Namespace Prefix: |
dei_ |
Data Type: |
dei:edgarExchangeCodeItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionBoolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.
+ ReferencesReference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Exchange Act -Number 240 -Section 14a -Subsection 12
+ Details
Name: |
dei_SolicitingMaterial |
Namespace Prefix: |
dei_ |
Data Type: |
xbrli:booleanItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionTrading symbol of an instrument as listed on an exchange.
+ References
+ Details
Name: |
dei_TradingSymbol |
Namespace Prefix: |
dei_ |
Data Type: |
dei:tradingSymbolItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionBoolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.
+ ReferencesReference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Securities Act -Number 230 -Section 425
+ Details
Name: |
dei_WrittenCommunications |
Namespace Prefix: |
dei_ |
Data Type: |
xbrli:booleanItemType |
Balance Type: |
na |
Period Type: |
duration |
|
Microvision (NASDAQ:MVIS)
Gráfico Histórico do Ativo
De Nov 2024 até Dez 2024
Microvision (NASDAQ:MVIS)
Gráfico Histórico do Ativo
De Dez 2023 até Dez 2024